Atelvia (uh-TEL-vee-uh), increases the chance for mishaps with osteoporosis meds

The new delayed-release risedronate, Atelvia (uh-TEL-vee-uh), increases the chance for mishaps with osteoporosis meds.

Atelvia is just Actonel with a special coating...that's supposed to reduce interference with calcium, iron, and other minerals.

Atelvia will be promoted as more convenient because it's taken AFTER breakfast...instead of 30 to 60 minutes BEFORE breakfast like Actonel and other oral "bisphosphonates."

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote